CompanySNDXNasdaqNew York, NY

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company developing cancer therapies.

SEC EDGAR ClinicalTrials.gov syndax.com

10-KSep 28Latest SEC filing

Aug 4Latest story

August 2026

Syndax reports 2Q26 revenue growth, details EGFR and menin inhibitor pipeline additions

Aug 4Quarterly updaterevumenib Syndax Pharmaceuticals Inc